BERKELEY, CA (UroToday.com) - Drinking a nice warm cup of green tea has
long been touted for its healthful benefits, both real and anecdotal.
But now researchers have found that a component of green tea, combined
with low doses of a COX-2 inhibitor, could slow the spread of human
prostate cancer.

In the March 1 issue of Clinical Cancer Research, researchers from
University of Wisconsin-Madison demonstrate that low doses of the COX-2
inhibitor celecoxib, administered with a green tea polyphenol called
pigallocatechin-3-gallate (EGCG), can slow the growth of human prostate
cancer. Their experiments were performed in cell cultures and in a mouse
model for the disease.